Sanskriti Medisciences LLP

Description:-
A non-steroidal anti-androgen that blocks the action of androgens (male hormones) in the body, slowing or stopping the growth of prostate cancer cell
 Enzandro 160mg Tablet is used to treat prostate cancer that has spread to other parts of the body or has not responded to other treatments.
Enzalutamide helps delay disease progression, reduce symptoms, and improve quality of life for patients with advanced prostate cancer.

Sigrima 420mg Injection is used to treat breast cancer. It belongs to group of medicine called monoclonal antibodies.

• Generic name: Pirfenidone

• Brand name: Pirfenex (by Cipla in India) 

• Dosage form: 200 mg film-coated oral tablet

• Primary use: Treats idiopathic pulmonary fibrosis (IPF) by slowing lung scarring 

• Used for treating advanced or metastatic renal cell carcinoma (RCC)

• Inhibits VEGFR-1, VEGFR-2, and VEGFR-3 to block tumor blood vessel growth (anti-angiogenic)

• Indicated after failure of one prior systemic therapy for kidney cancer

• Anti-Cancer Agent: Bevacizab contains Bevacizumab, a monoclonal antibody used to treat various cancers, including colorectal, lung, kidney, and glioblastoma, by inhibiting tumor growth.

• Mechanism of Action: It targets vascular endothelial growth factor (VEGF), blocking the formation of new blood vessels (angiogenesis) that supply nutrients to tumors, thereby slowing or stopping their growth.

• Administration & Monitoring: Given as an intravenous infusion under medical supervision; requires regular monitoring due to potential side effects such as hypertension, bleeding, and impaired wound healing.

Mabtas 500mg injection contains the active constituent rituximab. It is used for several different disease conditions in adults. It is used alone or with other medications to treat non-hodgkin’s lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukemia (a most common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a type of disease where the immune system attacks the body cells of its own joints)  in combination with methotrexate in adults. Mabtas Injection Uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals.  

Mabtas 500mg injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine, have a weak immune system, or have any severe active infection. Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment. Talk with your doctor if you have ever had a hepatitis B infection because the infection may reactivate again in a few cases and can be severe sometimes. Pregnancy and breastfeeding are not recommended when you are taking this injection.  

Common side effects of Mabtas 500mg injection include infection of the blood, reduced red blood cells, dizziness, swelling in the face and body, itchy skin, diarrhea, increased sweating, and low or high blood pressure. Use effective contraceptives during the treatment and 12 months after the last dose if you can get pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your physician or healthcare professional if you face any infusion reactions, such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.